Odawara, Japan

Maki Ohishi

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maki Ohishi. Retrieved from https://idiyas.com/inventor/maki-ohishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maki Ohishi: Innovator in Cyclodepsipeptide Research

Introduction

Maki Ohishi is a notable inventor based in Odawara, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of cyclodepsipeptides. His innovative work has led to the filing of a patent that showcases his expertise and dedication to scientific advancement.

Latest Patents

Maki Ohishi holds a patent for "Derivatives of cyclodepsipeptide PF 1022." This patent represents a crucial step in the exploration of cyclodepsipeptides and their potential applications in various industries, including pharmaceuticals.

Career Highlights

Ohishi is currently employed at Meiji Seika Kaisha, Ltd., a company known for its commitment to research and development in the food and pharmaceutical sectors. His role at the company allows him to further his research and contribute to innovative solutions in biochemistry.

Collaborations

Maki Ohishi has collaborated with talented coworkers, including Makoto Ohyama and Yumiko Okada. Their combined efforts in research have fostered a productive environment that encourages innovation and scientific discovery.

Conclusion

Maki Ohishi's contributions to the field of cyclodepsipeptides exemplify the impact of dedicated inventors in advancing scientific knowledge. His work continues to inspire future innovations in biochemistry and related fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…